Drug firm GSK delivers a syringe full of crowd-pleasers | Nils Pratley - The Guardian
- Drug firm GSK delivers a syringe full of crowd-pleasers | Nils Pratley The Guardian
- GSK delivers strong 2024 performance with further improvement to long-term growth outlook GSK
- GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion Investor's Business Daily
- GSK shares leap 5% as results top forecasts and guidance is upgraded! Can they keep rising? Motley Fool UK
- GSK launches £2bn share buyback and upgrades sales forecast The Times